Latest National Institute of Allergy and Infectious Diseases Stories
A team of scientists have for the first time developed a vaccine for malaria that has been found to be 100 percent effective in a small clinical trial. The vaccine, known as PfSPZ Vaccine, was developed by Sanaria Inc.
Inflamax Research today announces a collaboration with the Immune Tolerance Network (ITN), which is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US
Baylor College of Medicine researchers will lead a three-year, $4.2 million study funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to determine whether drugs called beta blockers can ease airway narrowing in patients with asthma and examine potential mechanisms.
- The abrogation of a law by a higher authority; annulment.